autism spectrum disorders - autism
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Ability to comply with the protocol-specified procedures for the duration of the study IQ above 70 Written informed consent (and assent if appropriate to local laws and regulations), In case of methylphenidate use, willingness to skip methylphenidate on the testing days For epilepsy groups: Males and females aged 7-12, Diagnosis of epilepsy and ASD symptoms (SRS50+ or diagnosis according to ADOS, or probable/definite difference at SP-NLor behavioral problems indicative of sensory processing problems (problems at school, irritability etc) For ASD group: Males and females aged 7-12, Diagnosis according to ADOS or given by psychiatrist For control group: Males and females aged 7-15, No psychiatric disorder present
Exclusion criteria
Exclusion criteria: Major visual or auditory impairment Presence of severe medical disorder Other (psychiater) disorders other than epilepsy or ASD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: The main outcome parameters are EEG markers: brain evoked P50 suppression, P300, mismatch negativity and absolute resting-state power change. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: Other EEG phenotypes, neurocognitive and behavioural parameters. | — |
Countries
Netherlands